2024-11-22 05:56:11
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
Health/ 2023-08-16
AffaMed Therapeutics Announces Partner V...

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years

Singapore's Top SMEs Honoured at the SME100 Awards 2023 Singapore
Singapore's Top SMEs Honoured at th...

SINGAPORE,Aug. 11,2023-- The highly anticipated SME100 Awards 2023 Singapore award ceremony took place at the prestigious Marina Bay Sands,c...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release